Note

Classification of financial instruments
Financial assets

	As at 31.12.2016	As at 31.12.2015 * restated
At fair value through profit or loss	8 435	4 174
Loans and receivables	1 376 667	1 248 060
Cash and cash equivalents	641 711	753 144
Available-for-sale financial assets	13 179	13 204
	2 039 992	2 018 582
Recognised in the statement of financial position as:
Available-for-sale financial assets	12 345	12 370
Trade and other receivables	785 003	745 837
Cash and cash equivalents	641 711	753 144
Derivatives	8 435	4 174
Other financial assets	592 498	503 057
	2 039 992	2 018 582

* Financial information restated as presented in point 2.3 of the notes to the consolidated financial statements.

Financial liabilities

	As at 31.12.2016	As at 31.12.2015* restated
At fair value through profit or loss	8 213	986
At amortised cost	2 577 035	2 216 749
	2 585 248	2 217 735
Recognised in the statement of financial position as:
Non-current loans	1 372 047	1 047 450
Current loans	52 034	118 880
Derivatives	8 213	986
Trade and other payables	1 070 367	977 635
Other non-current financial liabilities	15 102	16 112
Other current financial liabilities	67 485	56 672
	2 585 248	2 217 735

* Financial information restated as presented in point 2.3 of the notes to the consolidated financial statements.

Profit/(loss) on categories of financial instruments (+/-)

	For the period 01.01.2016 - 31.12.2016	For the period 01.01.2015 - 31.12.2015
Financial assets
At fair value through profit or loss	5 085	396
Loans and receivables	1 476	-
Cash and cash equivalents	656	-
Available-for-sale financial assets	-	4 472
Financial liabilities
At fair value through profit or loss	(7 387)	78
At amortised cost	(104)	-
	(274)	4 946

The above information does not include gains and losses concerning interest and foreign exchange rate gains or losses.

Additionally we inform that:

there were no financial assets presented in the statement of financial position as at 31 December 2016 and 31 December 2015 for which the terms and conditions were renegotiated,
except for the impairment losses on receivables presented in Note 17, the Group did not recognise other impairment losses concerning financial instruments,
no reclassifications of financial assets resulting from their maturities at the reporting dates occurred in 2016 and 2015,
no instruments containing both a liability and an equity component as well as containing embedded derivatives were issued in 2016 and 2015,
in 2016 and 2015 the Group did not seize any collaterals.